Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Hepatitis C Virus”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01903954
What this trial is testing

Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 283
Testing effectiveness (Phase 2)UnknownNCT01335711
What this trial is testing

CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects

Who this might be right for
Chronic Hepatitis C
ChronTech Pharma AB 32
Testing effectiveness (Phase 2)Study completedNCT00446134
What this trial is testing

Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)

Who this might be right for
Chronic Hepatitis C
Bausch Health Americas, Inc. 278
Not applicableStudy completedNCT02581163
What this trial is testing

Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium

Who this might be right for
Chronic Hepatitis C, Genotype 1 or 4
AbbVie 314
Large-scale testing (Phase 3)Study completedNCT00265395
What this trial is testing

Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 1,428
Testing effectiveness (Phase 2)Study completedNCT01030432
What this trial is testing

Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 285
Testing effectiveness (Phase 2)Study completedNCT00517439
What this trial is testing

Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 516
Not applicableStudy completedNCT02725866
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 216
Post-approval studies (Phase 4)Study completedNCT00680173
What this trial is testing

Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients

Who this might be right for
Chronic Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 30
Early research (Phase 1)Study completedNCT01818856
What this trial is testing

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir

Who this might be right for
Hepatitis C, ChronicHIV Infection
Hospitales Universitarios Virgen del Rocío 14
Not applicableStudy completedNCT03002818
What this trial is testing

Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)

Who this might be right for
Chronic Hepatitis C Virus (HCV)
AbbVie 41
Large-scale testing (Phase 3)Study completedNCT01579474
What this trial is testing

Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial

Who this might be right for
Hepatitis C
Boehringer Ingelheim 131
Post-approval studies (Phase 4)Study completedNCT00192647
What this trial is testing

Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 896
Testing effectiveness (Phase 2)Study completedNCT02226549
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 47
Large-scale testing (Phase 3)WithdrawnNCT01590225
What this trial is testing

Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT01753557
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C

Who this might be right for
Chronic Hepatitis C (CHC)
Tanabe Pharma Corporation 54
Testing effectiveness (Phase 2)Study completedNCT00097045
What this trial is testing

Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C

Who this might be right for
Hepatitis C
Intarcia Therapeutics 90
Large-scale testing (Phase 3)Ended earlyNCT00423800
What this trial is testing

Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 56
Large-scale testing (Phase 3)Study completedNCT01366638
What this trial is testing

TMC435 in Participants With Genotype 1 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 79
Large-scale testing (Phase 3)Study completedNCT01753570
What this trial is testing

Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)

Who this might be right for
Chronic Hepatitis C(CHC)
Tanabe Pharma Corporation 74
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation